Is GDRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GDRX. It does not provide personalized investment advice.

GDRX (GoodRx Holdings, Inc. Class A Common Stock) Stock Analysis - Financials

GoodRx Holdings, Inc. Class A Common Stock (GDRX) is a publicly traded Healthcare sector company. As of September 20, 2026, GDRX trades at $3.42 with a market cap of $1.15B and a P/E ratio of 68.40. GDRX moved -0.74% today. Year to date, GDRX is +24.72%; over the trailing twelve months it is -20.09%. Its 52-week range spans $1.77 to $5.81. Analyst consensus is neutral with an average price target of $4.21. Rallies surfaces GDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are GDRX's key financials?

GDRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GDRX recently traded at $3.42. Market cap is $1.15B. P/E ratio is 68.40. Revenue is $785.23M.

GDRX Key Metrics

Key financial metrics for GDRX
Metric	Value
Price	$3.42
Market Cap	$1.15B
P/E Ratio	68.40
EPS	$0.05
Dividend Yield	0.00%
52-Week High	$5.81
52-Week Low	$1.77
Volume	884.35K
Avg Volume	0
Revenue (TTM)	$785.23M
Net Income	$16.25M
Gross Margin	0.00%

GDRX Analyst Consensus

10 analysts cover GDRX: 0 strong buy, 4 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.21.

Common questions about GDRX

What are GDRX's key financials?: GDRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GDRX recently traded at $3.42. Market cap is $1.15B. P/E ratio is 68.40. Revenue is $785.23M.
Is GDRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GDRX. It does not provide personalized investment advice.